Federal Register: November 14, 2000 (Volume 65, Number 220)
DOCID: FR Doc 00-29011
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Docket ID: [Docket No. 00D-1555]
ACTION: Reports and guidance documents; availability, etc.:
DOCUMENT ACTION: Notice.
Draft Guidance for Industry on Refusal of Inspection or Access to HACCP Records Pertaining to the Safe and Sanitary Processing of Fish and Fishery Products; Availability
DATES: Submit written comments on the draft guidance by December 14, 2000. General comments on agency guidance documents are welcome at any time.
The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance for industry entitled ``Refusal of
Inspection or Access to HACCP Records Pertaining to the Safe and
Sanitary Processing of Fish and Fishery Products.'' This draft guidance
sets forth the agency's interpretation of its Hazard Analysis Critical
Control Point (HACCP) regulations for fish and fishery products as they
pertain to the inspection of facilities and records. The agency is
clarifying that a processor's refusal to allow FDA to inspect its
processing facilities, or to provide HACCP records or plans to an
inspector during an inspection, violates the regulations and [[Page 68151]]
thus may trigger a regulatory response by the agency. FDA is issuing this clarification because some domestic firms have questioned whether records can be made available after an inspection (rather than during) and some foreign firms have canceled scheduled inspections by FDA, but offered to make records available for review. This guidance applies to foreign processors that export fish and fishery products to the United States as well as to domestic processors.
HACCP records pertaining to safe and sanitary processing of fish and fishery products; inspection or access refusal,
FDA is announcing the availability of a draft guidance for industry entitled ``Refusal of Inspection or Access to HACCP Records Pertaining to the Safe and Sanitary Processing of Fish and Fishery Products.'' This guidance is intended to clarify that on site inspection of a processing facility and concurrent review of HACCP records are essential elements of FDA's Seafood HACCP program as set forth at part 123 (21 CFR part 123). These regulations require processors of fish and fishery products to operate preventive control systems for human food safety that incorporate the principles of HACCP. The regulations further provide that fish and fishery products are adulterated under section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 342(a)(4)) if their processor fails to have and implement a HACCP plan when one is necessary, or otherwise fails to meet any of the requirements of the regulations, including allowing the official review of records (Sec. 123.6(g)). Processors must make their HACCP records and plans available ``for official review and copying at reasonable times'' (Sec. 123.9(c)). The agency expects that it will regard the failure to provide records and plans by a domestic or foreign processor as a significant program violation, even if a firm volunteers the documents after the inspection.
FDA believes that the best way for a regulatory authority to determine whether a processor is effectively operating a HACCP system is by inspecting the processor to assess whether the system is operating properly and is appropriate for the circumstances. Review of monitoring and other records generated by the HACCP system is a critical component of an inspection because it allows the inspector to match records against practices and conditions being observed in the plant and it discourages fraud. Thus, FDA always has intended that its review of processors' HACCP plans and records would occur as part of an inspection of a processor's entire HACCP system.
For domestic processors, failure to allow an inspection would not only violate the HACCP regulations; it is also a prohibited act under section 301(f) of the act (21 U.S.C. 331(f)). Moreover, if a domestic processor refuses an FDA inspection, FDA can obtain an inspectional warrant from the U.S. district court in which the processor is located.
Failure to allow an FDA inspection by a foreign processor can also result in a regulatory response. The definition of ``processor'' at Sec. 123.3(l) specifically includes persons in foreign countries. Thus, like domestic processors, foreign processors who ship to the United States must operate under conditions that satisfy FDA's HACCP regulations, including the requirement that records be made available during the course of an FDA inspection.
This draft guidance is being issued consistent with FDA's good guidance practices (65 FR 56468, September 19, 2000). The draft guidance represents the agency's current thinking on refusal of inspection or access to HACCP records that pertain to the safe and sanitary processing of fish and fishery products. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statutes and regulations.
Interested persons may submit to the Dockets Management Branch (address above) written comments on the draft guidance. Two copies of any comments are to be submitted, except that individuals may submit one copy. Comments are to be identified with the docket number found in brackets in the heading of this document. The draft guidance and received comments are available for public examination in the Dockets Management Branch between 9 a.m. and 4 p.m., Monday through Friday.
Dated: October 30, 2000.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 0029011 Filed 111300; 8:45 am] BILLING CODE 416001F
FOR FURTHER INFORMATION CONTACT
Mary I. Snyder, Center for Food Safety and Applied Nutrition (HFS415), Food and Drug Administration, 200 C St. SW., Washington, DC 20204, 2024183133.